Jörg Reinhardt
Jörg Reinhardt | |
---|---|
Born | Homburg, Saarland, Germany | 11 March 1956
Education | University of Saarland (Ph.D., 1982) |
Occupation | Chairman of the Board of Directors of Novartis |
Spouse | Married |
Children | 2 |
Jörg Reinhardt (born 11 March 1956) is a German businessman who has been the chairman of the board of directors of the Swiss pharmaceutical group Novartis AG since 2013.[1][2] Since 2017, he has also been a member of the board of directors of the Swiss reinsurance group Swiss Re.[3]
Life and career
[edit]Reinhardt was born on 11 March 1956 in Homburg, Saarland, Germany.[4] He studied pharmacy at the University of Saarland and graduated in 1982 with a doctorate. He started his career in 1982 with Sandoz, who merged with Ciba-Geigy in 1996 to form Novartis.[4]
At Sandoz, he worked in research and development and became head of development in 1994. Following the merger into Novartis, Reinhardt was responsible for preclinical development throughout the group and later for the entire drug development. In 2008, he became Chief Operating Officer of Novartis.[5][4]
From 2000 to 2010 Reinhardt was President of the Board of Trustees of the Genomics Institute of the Novartis Research Foundation in the United States. From 2010 to 2012, he was Chairman of the Board of Management of Bayer HealthCare AG and Chairman of the Bayer HealthCare Executive Committee.[6]
In 2013, Reinhardt rejoined Novartis as chairman of the board.[4]
Other activities
[edit]Corporate boards
[edit]- Swiss Re, Non-Executive Independent Member of the Board of Directors (since 2017)
- Lonza Group, Member of the Board of Directors (2012-2013)[7]
- MorphoSys, Member of the Supervisory Board (2001-2004)[8]
- Temasek Holdings, Member of the European Advisory Panel [9]
Non-profit organizations
[edit]- Robert Koch Foundation, Member of the Board of Trustees[10]
Personal life
[edit]Reinhardt is married and father of two children.[4] He lives, since the completion of his studies, in Germany near Freiburg im Breisgau.[11]
References
[edit]- ^ Kristina Gnirke (19 February 2013). "Machtnetz von Jörg Reinhardt: Der Soldat". Bilanz Ringier Axel Springer Schweiz. Retrieved 12 December 2017.
- ^ "Jörg Reinhardt ist bescheiden und tough". Blick. 23 January 2013. Retrieved 12 December 2017.
- ^ "Novartis-Präsident soll in Swiss-Re-Verwaltungsrat". Handelszeitung Ringier Axel Springer Schweiz. Retrieved 12 December 2017.
- ^ a b c d e Jack, Andrew (8 December 2013). "Change without sour grapes". Financial Times.
- ^ "Novartis appoints Reinhardt as chief operating officer". Pharmafile. 24 October 2008. Retrieved 12 December 2017.
- ^ "Früherer Novartis-Mann Jörg Reinhardt wird neuer Leiter von Bayer HealthCare". SWI swissinfo. 21 April 2010. Retrieved 12 December 2017.
- ^ "Lonza verliert Verwaltungsrat Reinhardt". Handelszeitung Ringier Axel Springer Schweiz. Retrieved 12 December 2017.
- ^ "Neuer Leiter bei Bayer HealthCare". Konradin-Verlag. 4 May 2010. Retrieved 12 December 2017.
- ^ "Joerg Reinhardt, Ph.D." Novartis. Retrieved 3 July 2018.
- ^ Board of Trustees Archived 2021-12-28 at the Wayback Machine Robert Koch Foundation.
- ^ Marcolli, Patrick; Mensch, Christian (30 June 2021). "Bekenntnis des Novartis-Chefs Jörg Reinhardt: «Dass Basel der Hauptsitz bleibt, steht ausser Frage»" [Commitment of the head of Novartis Jörg Reinhardt: "The fact that Basel remains the headquarters is a question"]. Basellandschaftliche Zeitung (in Swiss High German).